Richard Aranda
Chief Tech/Sci/R&D Officer bei GOSSAMER BIO, INC.
Vermögen: 234 583 $ am 31.03.2024
Aktive Positionen von Richard Aranda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GOSSAMER BIO, INC. | Chief Tech/Sci/R&D Officer | 01.06.2021 | - |
| Corporate Officer/Principal | - | 01.06.2021 |
Karriereverlauf von Richard Aranda
Ehemalige bekannte Positionen von Richard Aranda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RECEPTOS INC | Corporate Officer/Principal | 01.01.2015 | 01.01.2018 |
| Novo-Nordisk Biochem, Inc. | Corporate Officer/Principal | 01.01.2011 | 01.01.2015 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.08.2001 | 01.05.2011 |
Ausbildung von Richard Aranda
| University of California, Santa Cruz | Undergraduate Degree |
| Stanford School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
| Novo-Nordisk Biochem, Inc. |
- Börse
- Insiders
- Richard Aranda
- Erfahrung
